secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bionano Genomics, Inc. (BNGO)
CIK:        0001411690
Form:       8-K
Filed at:   2024-04-08T23:59:59+00:00
Accession:  0001140361-24-018645
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bionano Genomics files $8.7M registered direct offering of common stock and warrants
--------------------------------------------------------------------------------

- Offering includes 6,536,682 common shares, pre-funded warrants for 2,196,944 shares, and warrants for 8,733,626 shares.
- Pre-funded warrants allow purchase of common stock at a nominal exercise price; warrants have exercise price and term set in prospectus.
- Legal opinion from Cooley LLP on validity of shares and warrant shares filed as Exhibit 5.1.
- Proceeds intended for general corporate purposes; no specific pricing or discount disclosed in this 8-K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1411690/000114036124018645/0001140361-24-018645-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1411690/000114036124018645/ny20026243x2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-018645

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer